Display Settings:

Format

Send to:

Choose Destination
    Neurology. 2008 May 6;70(19):1691-8.

    Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

    Source

    Department of Neurology, Mount Sinai Medical Center, New York, NY, USA.

    Abstract

    OBJECTIVE:

    To perform an evidence-based review of the safety and efficacy of botulinum neurotoxin (BoNT) in the treatment of adult and childhood spasticity.

    METHODS:

    A literature search was performed including MEDLINE and Current Contents for therapeutic articles relevant to BoNT and spasticity. Authors reviewed, abstracted, and classified articles based on American Academy of Neurology criteria (Class I-IV).

    RESULTS:

    The highest quality literature available for the respective indications was as follows: adult spasticity (14 Class I studies); spastic equinus and adductor spasticity in pediatric cerebral palsy (six Class I studies).

    RECOMMENDATIONS:

    Botulinum neurotoxin should be offered as a treatment option for the treatment of spasticity in adults and children (Level A).

    PMID:
    18458229
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for HighWire Press

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk